Matteo Materazzi's battle against a rare form of ALS has prompted his wife to launch a fundraiser to fund personalized ...

NeuroSense completed a Phase 2a clinical trial which met its safety and efficacy endpoints including reducing functional and ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

The amendment states that no funds appropriated in the fiscal 2026 spending bill can be used to increase the proportion of ...

Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's ...

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

Neuralink begins trial in UK to test brain chip implants, which is aimed at helping people with paralysis control devices ...

British patients are set to receive Elon Musk 's Neuralink brain chips as part of the first UK clinical trial. Neuralink is ...

Neuralink said patients living with paralysis due to conditions such as spinal cord injury and a nervous system disease can qualify to participate in the study.

The company is partnering with the University College London Hospitals trust and Newcastle Hospitals to conduct the study, it ...

Neuralink, Elon Musk's brain implant company, is expanding its clinical trials to the UK after its US success. The trials aim ...